Business Context and Reporting Period
This Form 8-K, dated February 1, 2016, reports that Balchem Corporation (Balchem) entered into a definitive Stock Purchase Agreement to acquire Albion International, Inc. (Albion International), a privately held manufacturer of mineral amino acid chelates and specialized mineral salts headquartered in Clearfield, Utah. The transaction closed on February 1, 2016.
Key Financial Metrics
- Purchase Price: $111,524,000 in cash, subject to adjustments based on Albion International's cash balances, working capital, outstanding indebtedness, and unpaid transaction costs at closing.
- Escrow Amount: $10,000,000 of the purchase price was deposited into an escrow account to secure post-closing obligations.
- Escrow Duration: Funds are generally held for 18 months following the closing date.
- Revenue, Profit, and Cash Flow: The filing text does not provide specific revenue, profit, cash flow, margin, or debt figures for Balchem or Albion International.
Material Changes
The primary material change is the acquisition of 100% of the issued and outstanding shares of Albion International. This expands Balchem's product portfolio into mineral amino acid chelates and specialized mineral salts. The transaction was funded entirely in cash, subject to working capital and debt adjustments.
Guidance, Risks, and Contingencies
- Indemnification: Sellers have agreed to indemnify Balchem against losses resulting from breaches of representations, covenants, pre-closing indebtedness, environmental conditions, and pending litigation.
- Survival Period: Representations and warranties generally survive for 18 months after the closing date.
- Non-Competition: The agreement includes non-competition and non-solicitation covenants by H. DeWayne Ashmead and certain senior executives.
- Forward-Looking Statements: The filing includes standard disclaimers that future expectations involve risks and uncertainties, referencing risks detailed in Balchem's 2014 Form 10-K.
Investor Verification Checklist
- Verify the final purchase price after working capital, cash, and debt adjustments.
- Review the press release (Exhibit 99.1) for strategic rationale and expected synergies.
- Monitor the 18-month escrow period for any claims or releases of the $10 million held.
- Assess the impact of the acquisition on Balchem's balance sheet and liquidity in subsequent quarterly reports.
- Check for any undisclosed liabilities related to environmental conditions or litigation that may trigger indemnification.